Published in Gut on November 01, 2002
Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg (2004) 5.12
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol (2012) 2.59
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut (2011) 1.94
Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer. J Natl Cancer Inst (2014) 1.69
Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg (2010) 1.56
Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr Genomics (2011) 1.33
Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol (2010) 1.20
Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J Surg (2010) 1.08
Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity. Virchows Arch (2007) 1.06
Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist (2010) 1.06
Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology (2009) 1.04
Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes. Cancer (2010) 1.00
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio. Ann Surg (2010) 0.98
Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. World J Gastrointest Oncol (2014) 0.98
Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience. World J Surg (2008) 0.97
Comparison of resected and non-resected intraductal papillary mucinous neoplasms of the pancreas. World J Surg (2005) 0.96
PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas. Langenbecks Arch Surg (2008) 0.94
Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther (2012) 0.94
Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications. World J Surg Oncol (2010) 0.92
Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas. Pancreas (2008) 0.89
Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease. Nat Rev Gastroenterol Hepatol (2012) 0.89
Management of mucin-producing cystic neoplasms of the pancreas. Oncologist (2009) 0.89
Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy. World J Gastrointest Oncol (2012) 0.88
Oncocytic-type intraductal papillary mucinous neoplasm (IPMN)-derived invasive oncocytic pancreatic carcinoma with brain metastasis - a case report. World J Surg Oncol (2012) 0.87
Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg (2010) 0.86
Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg (2010) 0.86
Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis. Pancreas (2012) 0.86
Management of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol (2008) 0.85
Pylorus- and spleen-preserving total pancreatoduodenectomy with resection of both whole splenic vessels: feasibility and laparoscopic application to intraductal papillary mucin-producing tumors of the pancreas. Surg Endosc (2012) 0.84
Cystic tumours of the pancreas. HPB (Oxford) (2007) 0.84
Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results. J Exp Clin Cancer Res (2008) 0.84
mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN). Gut (2013) 0.83
How fibrosis influences imaging and surgical decisions in pancreatic cancer. Front Physiol (2012) 0.82
Endoscopic ultrasonography for evaluating patients with recurrent pancreatitis. World J Gastroenterol (2008) 0.82
[Intraductal neoplasms of the pancreas: cystic and common]. Pathologe (2005) 0.81
Management of Incidental Pancreatic Cystic Lesions. Viszeralmedizin (2015) 0.79
Postoperative recurrence of an IPMN of the pancreas with a fistula to the stomach. World J Gastrointest Endosc (2010) 0.78
Malignant potential of intraductal papillary mucinous neoplasms of the pancreas. Surg Today (2010) 0.77
Outcomes of surgery for intraductal papillary mucinous neoplasms of the pancreas. World J Surg (2006) 0.77
Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas. World J Gastroenterol (2015) 0.77
Total pancreatectomy for recurrent intraductal papillary mucinous carcinoma in remnant pancreas of pancreaticoduodenectomy for intraductal papillary mucinous adenocarcinoma. BMJ Case Rep (2013) 0.75
Increased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literature. World J Gastroenterol (2015) 0.75
Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy. Viszeralmedizin (2015) 0.75
Cystic neoplasms of the pancreas. Surg Oncol Clin N Am (2010) 0.75
Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions. Endosc Ultrasound (2016) 0.75
Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms. J Cancer Res Clin Oncol (2016) 0.75
Pancreatic resections in renal failure patients: is it worth the risk? HPB Surg (2014) 0.75
Differential diagnosis between intraductal papillary mucinous neoplasm with an associated invasive carcinoma and pancreatic ductal adenocarcinoma on ultrasonography: the utility of echo intensity and contrast enhancement. Ultrasonography (2017) 0.75
Predictors of early stages of histological progression of branch duct IPMN. Langenbecks Arch Surg (2014) 0.75
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51
Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg (1995) 4.17
Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg (2001) 2.80
Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol (2000) 2.58
Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg (1999) 2.33
Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology (1996) 2.33
Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg (1994) 1.84
Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc (1998) 1.78
Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg (1998) 1.76
Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut (1996) 1.74
Intraductal neoplasms of the pancreas. Am J Surg (1998) 1.69
Results of extensive surgery for pancreatic carcinoma. Cancer (1996) 1.60
Prognostic value of CA 19-9 serum course in pancreatic cancer. Hepatogastroenterology (1998) 1.58
Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg (2001) 1.53
Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg (1996) 1.46
"Ductectatic" mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology (1986) 1.41
The prognosis of intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology (2001) 1.37
Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms. Ann Surg (1996) 1.36
Two types of mucin-producing cystic tumors of the pancreas: diagnosis and treatment. Surgery (1997) 1.24
Intraductal papillary mucinous tumors of the pancreas. Am J Surg (1999) 1.23
Intraductal papillary mucinous tumor of the pancreas. Am J Surg (1999) 1.18
Duct-ectatic type of mucin producing tumor of the pancreas--new concept of pancreatic neoplasia. Hepatogastroenterology (1997) 1.16
Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature. Am J Gastroenterol (2001) 1.02
Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery (2000) 1.00
[Intraductal papillary mucinous tumors of the pancreas. Clinical and morphological aspects in 30 patients]. Gastroenterol Clin Biol (1997) 1.00
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol (2005) 5.82
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology (2000) 3.49
Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg (1999) 3.09
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med (2001) 2.95
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology (2001) 2.73
Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. Am J Transplant (2015) 2.71
Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol (1999) 2.67
Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut (2000) 2.67
Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet (2002) 2.65
Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol (2000) 2.58
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol (2004) 2.54
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest (1995) 2.45
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol (2004) 2.39
Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 months. Thorax (1997) 2.37
The natural history of hereditary pancreatitis: a national series. Gut (2008) 2.33
Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol (1999) 2.33
Characterization of obstructive nonapneic respiratory events in moderate sleep apnea syndrome. Am J Respir Crit Care Med (2001) 2.33
Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy (1993) 2.31
Complications of double balloon enteroscopy: a multicenter survey. Endoscopy (2007) 2.28
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol (2006) 2.28
Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci (1992) 2.26
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology (2000) 2.21
Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut (2002) 2.21
Primary malignant melanoma of the esophagus: a case report and review of the literature. Dis Esophagus (2002) 2.20
Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology (2000) 2.16
Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics (2000) 2.15
Randomized clinical trial of ischaemic preconditioning in major liver resection with intermittent Pringle manoeuvre. Br J Surg (2011) 2.15
Small bowel metastases from primary carcinoma of the lung: clinical findings and outcome. Am J Gastroenterol (1999) 2.14
Adult celiac disease with severe or partial villous atrophy: a comparative study. Gastroenterol Clin Biol (2008) 2.04
Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc (2001) 1.94
CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol (1995) 1.93
Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg (1999) 1.92
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology (2001) 1.87
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol (2013) 1.82
Laparoscopy extends the indications for liver resection in patients with cirrhosis. Br J Surg (1999) 1.79
Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease. Br J Surg (1999) 1.79
Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc (1998) 1.78
Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med (1999) 1.73
Epithelioid hemangioendothelioma, multiple focal nodular hyperplasias, and cavernous hemangiomas of the liver. Arch Pathol Lab Med (1999) 1.71
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer (2006) 1.71
Diagnosis and conservative management of intrathoracic leakage after oesophagectomy. Br J Surg (1998) 1.70
Cytolysis following chemoembolization for hepatocellular carcinoma. Br J Surg (1999) 1.70
Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study. Lancet (2001) 1.69
Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene (2001) 1.68
Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis (2006) 1.67
Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut (1999) 1.67
Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep (1995) 1.66
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut (2005) 1.65
High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J (1999) 1.63
Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut (2000) 1.63
Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study. Eur Respir J (2009) 1.62
Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. Histopathology (1998) 1.61
Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol (2001) 1.61
Long-term outcome of patients with gastrointestinal bleeding of obscure origin explored by push enteroscopy. Endoscopy (2002) 1.60
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol (2000) 1.59
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur J Immunol (1993) 1.58
Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol (2000) 1.57
Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg (2006) 1.57
Easy clip to treat anal fistula tracts: a word of caution. Int J Colorectal Dis (2015) 1.55
Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology (1994) 1.54
Push-and-pull enteroscopy in the small bowel using the double-balloon technique: results of a prospective European multicenter study. Endoscopy (2005) 1.53
In situ split liver transplantation for two adult recipients. Transplantation (2000) 1.53
Sclerosing cholangitis induced by formaldehyde solution injected into the biliary tree of rats. Arch Surg (1990) 1.52